Jun 14 |
AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate
|
Jun 14 |
AbbVie joins in latest gastrointestinal drug chase
|
Jun 14 |
The Dividend Defenders: 3 Stocks That Will Protect and Grow Your Wealth Dividend Stocks
|
Jun 14 |
AbbVie and FutureGen link on inflammatory bowel disease
|
Jun 13 |
Here's How Many Shares Of AbbVie You Would Need To Earn $500 Per Month In Dividends
|
Jun 13 |
AbbVie inks licensing pact for bowel disorder therapy
|
Jun 13 |
AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory Bowel Disease
|
Jun 12 |
AbbVie, Inc. (ABBV) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
|
Jun 12 |
Blue-Chip Bonanzas: 3 Industry Leaders Trading at Unbelievable Discounts
|
Jun 12 |
Cerevel Therapeutics gains after AbbVie says making good progress with FTC
|